TBX-2400

N/A

Report date: 2025/01/02 16:12:12

Base Information

Drug NameTBX-2400
Drug Alias NameTBX-2400TBX2400
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsPrimary MyelofibrosisLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyCroatia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaiga Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesTaiga Biotechnologies Inc
Inactive CompaniesN/A
Active IndicationsPrimary MyelofibrosisLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A